01.09.2007 | Clinical Article
Effects of the selective endothelin A (ETA) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage – preliminary results from a randomized clinical series
Erschienen in: Acta Neurochirurgica | Ausgabe 9/2007
Einloggen, um Zugang zu erhalten